Improving colorectal cancer screening access through community health centers
Official title: Eliminating Barriers to Colorectal Cancer Screening Using Rapid Cycle Testing: A Pilot Study
Run by Massachusetts General Hospital · NCT05524428 · Data updated 2026-11-12
This study is trying to find out how to make it easier for people aged 45 and older to get screened for colorectal cancer at community health centers in Massachusetts.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 2 (estimated) |
| Sponsor | Massachusetts General Hospital Academic / other |
| Locations | 4 sites (Boston, Massachusetts and 3 other locations) |
| Status | Recruiting |
| Started | March 24, 2023 |
| Main results expected | December 2026 |
| Study ends | December 2026 |
| Registry record updated | November 14, 2025 |
| Trial ID | NCT05524428 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are community health center staff involved in colorectal cancer screening practices.
✕Probably not a fit
Patients who are not affiliated with the participating community health centers or who do not engage in colorectal cancer screening will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot study aims to identify and eliminate barriers to colorectal cancer screening by analyzing demographic data and screening patterns among populations aged 45 and older. The investigators will conduct focus groups with community health center staff and utilize electronic health records to assess current screening practices and resource needs. By understanding the disparities in screening initiation, the study seeks to inform strategies for expanding screening eligibility and improving health equity. The research will take place in four diverse community health centers in Massachusetts.
Why it matters
Potential benefit: If successful, this study could enhance access to colorectal cancer screening for underserved populations, potentially leading to earlier detection and improved outcomes.
How similar studies have gone: Other studies have shown success in using implementation science strategies to improve cancer screening rates, indicating that this approach has potential.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Staff members at partnering sites (see locations) who are administrative leaders, population health managers, data analysts, quality improvement staff, nurses, nurse managers, practice managers, medical assistants, and providers. * Staff members at partnering sites ages 18+. Exclusion Criteria: * Staff members that are not involved in CRC screening practices at CHCs.
Where it's running
-
Codman Square Health Center
Boston, Massachusetts, United States Recruiting -
Brockton Neighborhood Health Center
Brockton, Massachusetts, United States Recruiting -
East Boston Neighborhood Health Center
East Boston, Massachusetts, United States Recruiting -
Duffy Health Center
Hyannis, Massachusetts, United States Recruiting
Study contacts
- Principal investigator: Adjoa Anyane-Yeboa, MD, MPH — Mass General Hospital // Harvard Medical School
- Study coordinator: Adjoa Anyane-Yeboa, MD, MPH
- Email: aanyane-yeboa@mgh.harvard.edu
- Phone: 617-726-2426
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Prehabilitation before high-risk cancer surgery
This trial tests a multidisciplinary prehabilitation program to see if it helps adults with cancer recover better after major abdominal surgery.
-
Personal cancer risk testing using genetic, blood, and tumor monitoring
This project will test whether combining genetic testing, blood-based analyses, and tumor tissue checks can identify personal cancer risk and detect early recurrence in adults with breast, ovarian, colorectal, melanoma, or certain non-small cell lung cancers.
-
Liquid biopsy and machine learning to detect early colorectal cancer, advanced adenomas, Lynch-related cancers, and residual disease
This project will test a blood-based liquid biopsy that uses microRNA signals and machine learning to detect colorectal cancer, advanced adenomas, Lynch-associated cancers, and molecular residual disease in people who have a colonoscopy.
-
Colorectal Cancer Screening Outreach for Better Adherence
This trial tests a bundled messaging approach to help adults at risk complete colorectal cancer screening.
-
Blood-based delta-HLD methylation test for detecting colorectal cancer
This will try a blood-based delta-HLD methylation test to see if it can detect colorectal cancer in people scheduled for colonoscopy or colorectal surgery.
-
MBRC-201 dose-finding and safety in advanced metastatic solid tumors
We will test different doses of an antibody-drug conjugate called MBRC-201 in adults whose advanced metastatic cancers (including prostate, breast, colorectal, lung, and pancreatic cancer) have not responded to standard treatments.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.